Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $215.50 | 8 | 68.5% |
| Education | $99.02 | 1 | 31.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Aries Pharmaceuticals, Inc. | $99.02 | 1 | $0 (2017) |
| BOSTON SCIENTIFIC CORPORATION | $90.18 | 1 | $0 (2018) |
| PFIZER INC. | $40.43 | 2 | $0 (2021) |
| Takeda Pharmaceuticals U.S.A., Inc. | $38.71 | 2 | $0 (2021) |
| AbbVie, Inc. | $20.03 | 1 | $0 (2017) |
| Allergan Inc. | $13.42 | 1 | $0 (2017) |
| QOL Medical, LLC | $12.73 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $48.13 | 2 | PFIZER INC. ($25.07) |
| 2019 | $28.38 | 2 | Takeda Pharmaceuticals U.S.A., Inc. ($15.65) |
| 2018 | $105.54 | 2 | BOSTON SCIENTIFIC CORPORATION ($90.18) |
| 2017 | $132.47 | 3 | Aries Pharmaceuticals, Inc. ($99.02) |
All Payment Transactions
9 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/20/2021 | PFIZER INC. | INFLECTRA (Biological) | Food and Beverage | In-kind items and services | $25.07 | General |
| Category: INFLAMMATION | ||||||
| 04/23/2021 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $23.06 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/23/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Entyvio (Biological) | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: Lower GI | ||||||
| 08/14/2019 | QOL Medical, LLC | Sucraid (Drug) | Food and Beverage | Cash or cash equivalent | $12.73 | General |
| Category: THERAPY FOR CSID | ||||||
| 11/30/2018 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 03/15/2018 | BOSTON SCIENTIFIC CORPORATION | GENERAL THERAPIES (Device) | Food and Beverage | In-kind items and services | $90.18 | General |
| Category: THERAPIES | ||||||
| 10/15/2017 | Aries Pharmaceuticals, Inc. | MB MMX (Drug), ELEVIEW | Education | In-kind items and services | $99.02 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/08/2017 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: Immunology | ||||||
| 01/11/2017 | Allergan Inc. | VIBERZI (Drug) | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 1 | 17 | 18 | $4,686 | $962.20 |
All Medicare Procedures & Services
1 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 17 | 18 | $4,686 | $962.20 | 20.5% |
About Dr. John Harrington, MD
Dr. John Harrington, MD is a Gastroenterology healthcare provider based in Kenner, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/17/2005. The National Provider Identifier (NPI) number assigned to this provider is 1437154259.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Harrington, MD has received a total of $314.52 in payments from pharmaceutical and medical device companies, with $48.13 received in 2021. These payments were reported across 9 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($215.50).
As a Medicare-enrolled provider, Harrington has provided services to 17 Medicare beneficiaries, totaling 18 services with total Medicare billing of $962.20. Data is available for 1 year (2020–2020), covering 1 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Kenner, LA
- Active Since 06/17/2005
- Last Updated 01/27/2016
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1437154259
Products in Payments
- MB MMX (Drug) $99.02
- GENERAL THERAPIES (Device) $90.18
- INFLECTRA (Biological) $25.07
- ENTYVIO (Biological) $23.06
- Humira (Biological) $20.03
- Entyvio (Biological) $15.65
- XELJANZ (Drug) $15.36
- VIBERZI (Drug) $13.42
- Sucraid (Drug) $12.73
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.